Molecular Pathogenesis and Management of Atopic Dermatitis: A Comprehensive Review
DOI:
10.29303/jbt.v25i4.10131Published:
2025-10-09Downloads
Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin disease with rising global prevalence and substantial health and psychosocial burden. This review aims to summarize recent advances in molecular pathogenesis and management of AD. Literature was searched in PubMed, ScienceDirect, Google Scholar, and accredited national journals, focusing on the past ten years. Inclusion criteria were full-text articles in English or Indonesian addressing epidemiology, pathogenesis, clinical features, and management. Irrelevant or incomplete studies were excluded. Selected articles were screened, classified by theme, and analyzed narratively following PRISMA guidelines. Findings show that AD prevalence continues to increase worldwide, with major impacts from chronic pruritus, recurrent flares, and psychosocial distress. Key mechanisms include genetic predisposition, especially filaggrin mutations, and immune dysregulation involving Th2, Th17, and Th22 pathways. Current treatments range from topical therapies to biologics and JAK inhibitors, emphasizing individualized care. In conclusion, AD is a lifelong multifactorial disease requiring comprehensive management. Advances in pathophysiology have expanded therapeutic options, with biologics and JAK inhibitors showing strong efficacy. Globally, priorities include precision medicine, early intervention, and wider access to novel therapies. In Indonesia, urgent needs are early detection in primary care, integration of AD management into national health programs, and ensuring affordable treatment access.
Keywords:
Allergy, atopic dermatitis, eczema, pathogenesis, management.References
Baidya, A., & Mabalirajan, U. (2025). Pathogenesis and management of atopic dermatitis: Insights into epidermal barrier dysfunction and immune mechanisms. Exploration of Asthma & Allergy, 100973. https://doi.org/10.37349/eaa.2025.100973
Boguniewicz, M., Fonacier, L., Guttman-Yassky, E., Ong, P. Y., Silverberg, J., & Farrar, J. R. (2018). Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape. Annals of Allergy, Asthma & Immunology, 120(1), 10-22.e2. https://doi.org/10.1016/j.anai.2017.10.039
Choo, Z.-Y., Mehlis, S. L., & Joyce, J. C. (2024). Updates in atopic dermatitis for the primary care physician: A review of advances in the understanding and treatment of atopic dermatitis. Disease-a-Month, 70(4), 101687. https://doi.org/10.1016/j.disamonth.2024.101687
Chow, S., Seow, C. S., Dizon, M. V., Godse, K., Foong, H., Chan, V., Khang, T. H., Xiang, L., Hidayat, S., Listiawan, Y. M., Triwahyudi, D., Gondokaryono, S. P., Sutedja, E., Diana, I. A., Suwarsa, O., Dharmadji, H. P., Siswati, A. S., Danarti, R., Soebaryo, R., & Budianti, W. K. (2018). A clinician’s reference guide for the management of atopic dermatitis in Asians. Asia Pacific Allergy, 8(4), e41. https://doi.org/10.5415/apallergy.2018.8.e41
Chu, D. K., Chu, A. W. L., Rayner, D. G., Guyatt, G. H., Yepes-Nuñez, J. J., Gomez-Escobar, L., Pérez-Herrera, L. C., Díaz Martinez, J. P., Brignardello-Petersen, R., Sadeghirad, B., Wong, M. M., Ceccacci, R., Zhao, I. X., Basmaji, J., MacDonald, M., Chu, X., Islam, N., Gao, Y., Izcovich, A., … Schneider, L. (2023). Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. Journal of Allergy and Clinical Immunology, 152(6), 1493–1519. https://doi.org/10.1016/j.jaci.2023.08.030
Chu, D. K., Schneider, L., Asiniwasis, R. N., Boguniewicz, M., De Benedetto, A., Ellison, K., Frazier, W. T., Greenhawt, M., Huynh, J., Kim, E., LeBovidge, J., Lind, M. L., Lio, P., Martin, S. A., O’Brien, M., Ong, P. Y., Silverberg, J. I., Spergel, J. M., Wang, J., … Chu, D. K. (2024). Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Institute of Medicine–based recommendations. Annals of Allergy, Asthma & Immunology, 132(3), 274–312. https://doi.org/10.1016/j.anai.2023.11.009
Hopkop, T., Fitri, E., Budianti, W., Sirait, S. P., & Miranda, E. (2023). Patogenesis dan tata laksana dermatitis atopik terkini. Media Dermatovenereologica Indonesiana, 50(2), 62–68. https://doi.org/10.33820/mdvi.v49i4.295
Hoy, S. M. (2023). Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis. American Journal of Clinical Dermatology, 24(1), 143–151. https://doi.org/10.1007/s40257-022-00748-2
Jeskey, J., Kurien, C., Blunk, H., Sehmi, K., Areti, S., Nguyen, D., & Hostoffer, R. (2024). Atopic Dermatitis: A Review of Diagnosis and Treatment. The Journal of Pediatric Pharmacology and Therapeutics, 29(6), 587–603. https://doi.org/10.5863/1551-6776-29.6.587
Katayama, I., Aihara, M., Ohya, Y., Saeki, H., Shimojo, N., Shoji, S., Taniguchi, M., & Yamada, H. (2017). Japanese guidelines for atopic dermatitis 2017. Allergology International, 66(2), 230–247. https://doi.org/10.1016/j.alit.2016.12.003
Langan, S. M., Irvine, A. D., & Weidinger, S. (2020). Atopic dermatitis. The Lancet, 396(10247), 345–360. https://doi.org/10.1016/S0140-6736(20)31286-1
Luger, T., Boguniewicz, M., Carr, W., Cork, M., Deleuran, M., Eichenfield, L., Eigenmann, P., Fölster‐Holst, R., Gelmetti, C., Gollnick, H., Hamelmann, E., Hebert, A. A., Muraro, A., Oranje, A. P., Paller, A. S., Paul, C., Puig, L., Ring, J., Siegfried, E., … Wahn, U. (2015). Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants. Pediatric Allergy and Immunology, 26(4), 306–315. https://doi.org/10.1111/pai.12331
Manurung, T. H. P., Fitri, E. M., Budianti, W. K., Sirait, S. P., & Miranda, E. (2023). Patogenesis dan tata laksana dermatitis atopik terkini. Media Dermato-Venereologica Indonesiana, 50(2), 62–68. https://doi.org/10.33820/mdvi.v49i4.295
McDowell, L., & Olin, B. (2019). Crisaborole: A Novel Nonsteroidal Topical Treatment for Atopic Dermatitis. Journal of Pharmacy Technology, 35(4), 172–178. https://doi.org/10.1177/8755122519844507
Müller, S., Maintz, L., & Bieber, T. (2024). Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs. Allergy, 79(6), 1501–1515. https://doi.org/10.1111/all.16009
Nankervis, H., Thomas, K. S., Delamere, F. M., Barbarot, S., Rogers, N. K., & Williams, H. C. (2016). Scoping systematic review of treatments for eczema. Programme Grants for Applied Research, 4(7), 1–480. https://doi.org/10.3310/pgfar04070
Nutten, S. (2015). Atopic Dermatitis: Global Epidemiology and Risk Factors. Annals of Nutrition and Metabolism, 66(Suppl. 1), 8–16. https://doi.org/10.1159/000370220
Oh, J., Kim, S., Kim, M. S., Abate, Y. H., Abd ElHafeez, S., Abdelkader, A., Abdi, P., Abdulah, D. M., Aboagye, R. G., Abolhassani, H., Abtahi, D., Abualruz, H., Abu-Gharbieh, E., Aburuz, S., Adane, M. M., Addo, I. Y., Adeleke, O. T., Aden, B., Adnani, Q. E. S., … Yon, D. K. (2025). Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: A systematic analysis of the Global Burden of Disease Study 2021. The Lancet Respiratory Medicine, 13(5), 425–446. https://doi.org/10.1016/S22132600(25)00003-7
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, n71. https://doi.org/10.1136/bmj.n71
PERDOSKI. (2017). Panduan praktik klinis bagi dokter spesialis kulit dan kelamin di indonesia [Clinical Practice Guideline]. Perhimpunan Dokter Spesialis Kulit dan Kelamin Indonesia.
PERDOSKI. (2024). Panduan diagnosis dan tata laksana dermatitis akut pada anak dan dewasa di indonesia [Clinical Practice Guideline]. Perhimpunan Dokter Spesialis Kulit dan Kelamin Indonesia (PERDOSKI).
Ramírez‐Marín, H. A., & Silverberg, J. I. (2022). Differences between pediatric and adult atopic dermatitis. Pediatric Dermatology, 39(3), 345–353. https://doi.org/10.1111/pde.14971
Saeki, H., Nakahara, T., Tanaka, A., Kabashima, K., Sugaya, M., Murota, H., Ebihara, T., Kataoka, Y., Aihara, M., Etoh, T., Katoh, N., & Committee for Clinical Practice Guidelines for the Management of Atopic Dermatitis of Japanese Dermatological Association. (2016). Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016. The Journal of Dermatology, 43(10), 1117–1145. https://doi.org/10.1111/13468138.13392
Sidbury, R., Alikhan, A., Bercovitch, L., Cohen, D. E., Darr, J. M., Drucker, A. M., Eichenfield, L. F., Frazer-Green, L., Paller, A. S., Schwarzenberger, K., Silverberg, J. I., Singh, A. M., Wu, P. A., & Davis, D. M. R. (2023). Guidelines of care for the management of atopic dermatitis in adults with topical therapies. Journal of the American Academy of Dermatology, 89(1), e1–e20. https://doi.org/10.1016/j.jaad.2022.12.029
Silverberg, J. I. (2017). Public Health Burden and Epidemiology of Atopic Dermatitis. Dermatologic Clinics, 35(3), 283–289. https://doi.org/10.1016/j.det.2017.02.002
Sroka-Tomaszewska, J., & Trzeciak, M. (2021). Molecular mechanisms of atopic dermatitis pathogenesis. International Journal of Molecular Sciences, 22(8), 4130. https://doi.org/10.3390/ijms22084130
Stacey, S. K., & McEleney, M. (2021). Topical Corticosteroids: Choice and Application. American Family Physician, 103(6), 337–343.
Sun, C., Zhang, X., Su, Z., Yao, W.-H., Chen, H.-D., & Zeng, Y.-P. (2025). Global, regional, and national burdens of atopic dermatitis from 1990 to 2021: A trend analysis from the Global Burden of Disease Study 2021. Journal of the American Academy of Dermatology, S0190962225023692. https://doi.org/10.1016/j.jaad.2025.06.042
License
Copyright (c) 2025 Ida Bagus Putra Bayu Aryasta, Hadian Rahman
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
